Cerebral venous thrombosis
Cerebral venous thrombosis is a rare disorder with highly variable and nonspecific clinical presentations. For these reasons, specific treatment should be given only when the diagnosis has been firmly established. Etiologic diagnosis should begin in the emergency department to identify underlying conditions that require specific treatment.
The mainstay of treatment is anticoagulation with heparin, even in the case of cerebral hemorrhage, followed as soon as possible by oral anticoagulant administration. The optimal duration of oral anticoagulation has not been established. By analogy with systemic venous thrombosis, it should be prolonged 3 to 6 months. When a high risk of recurrence is present, treatment should be continued until the risk disappears.
In contrast to arterial stroke, complete recovery of prolonged or severe neurologic deficit is possible, justifying initiation of anticoagulation even when the clinical situation seems desperate. For the same reason, aggressive treatment of intracranial hypertension and seizures or status epilepticus is warranted.
Screening for extraneurologic venous thrombosis should be done by means of clinical examination and, if necessary, specific imaging procedures.
Local thrombolysis is not yet of proven efficacy and safety. It can be used in patients with clinical worsening related to documented extension of the venous thrombosis despite anticoagulation and in the absence of cerebral hematoma.
Surgical treatment is limited to external ventricular drainage and suboccipital craniotomy in the very rare cases of cerebellar vein thrombosis with edematous cerebellar infarct.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 2.Bousser MG: Cerebral Venous Thrombosis. Philadelphia: W.B. Saunders Co.; 1997. The only recent reference book on CVT, describing pathophysiology, clinical presentation, diagnosis, prognosis, and treatment of all known forms of CVT.Google Scholar
- 3.Crawford SC, Digre KB, Palmer CA, et al.: Thrombosis of the deep venous drainage of the brain in adults. Arch Neurol 1995, 52:1101–1108. A precise clinical and radiologic description of seven cases of a rare but sometimes devastating form of CVT, diagnosis of which can often be suspected on unenhanced CT scanning.PubMedGoogle Scholar
- 8.Ozsvath RR, Casey SO, Lustrin ES, et al.: Cerebral venography: comparison of CT and MR projection venography. Am J Roentgenol 1997, 169:1699–1707. A rigorous comparative study showing that CT venography is at least as efficient as magnetic resonance venography in the diagnosis of CVT; it is possibly superior in the differential diagnosis of hypoplastic sinus with low-flow phenomenon and dural sinus thrombosis.Google Scholar
- 11.Martinelli I, Sacchi E, Landi G, et al.: High risk of cerebralvein thrombosis in carriers of a prothrombingene mutation and in users of oral contraceptives. N Engl J Med 1998, 338:1793–1797. A case-control study showing the high incidence of two congenital thrombophilia (factor V Leiden and prothrombin) mutations in idiopathic CVT and their interaction with oral contraceptive agents.PubMedCrossRefGoogle Scholar
- 18.Einhäupl KM, Villringer A, Meister W, et al.: Heparin treatment in sinus venous thrombosis. Lancet 1991, 338:597–600. The first randomized controlled trial in CVT, showing a diminution in deaths and handicapping together with good tolerance of heparin in CVT complicated by cerebral hemorrhage.PubMedCrossRefGoogle Scholar
- 19.Bergui M, Bradac GB, Danielle D: Brain lesions due to cerebral venous thrombosis do not correlate with sinus involvement. Neuroradiology 1999, 41:419–424. A multimodal radiologic study showing that parenchymatous lesions in CVT correlate with the involvement of cerebral veins, not the dural sinus.PubMedCrossRefGoogle Scholar
- 21.Einhäupl KM, Masuhr F: Cerebral venous and sinus thrombosis: an update. Eur J Neurol 1994, 1:109–126.Google Scholar
- 22.De Bruijn SFTM, Stam J: Randomized, placebo-controlled trial of anticoagulant treatment with lowmolecular-weight heparin for cerebral sinus thrombosis. Stroke 1999, 30:484–488. A randomized controlled trial of nadroparin versus placebo in CVT that was negative despite fewer deaths in the group receiving nadroparin.PubMedGoogle Scholar
- 24.Raschke RA, Reilly BM, Guidry JR, et al.: The weightbased heparin dosing nomogram compared with a “standard-care” nomogram. A randomized controlled trial. Ann Intern Med 1993, 119:874–881. Description of a weight-based nomogram and of a randomized controlled trial showing its efficiency and safety.PubMedGoogle Scholar
- 30.Gordon Smith A, Cornblath WT, Deveikis JP: Local thrombolytic therapy in deep cerebral venous thrombosis. Neurology 1997, 48:1613–1619.Google Scholar
- 35.Keller E, Flacke S, Urbach H, et al.: Diffusion- and perfusion-weighted magnetic resonance magnetic imaging in deep cerebral venous thrombosis. Stroke 1999, 30:1144–1146. A case report discussing the pathophysiology of the neurologic manifestations of CVT and its exploration with new magnetic resonance imaging techniques.PubMedGoogle Scholar